Evaxion Historical Balance Sheet

EVAX Stock

USD 1.66 0.09 5.73%

Trend analysis of Evaxion Biotech AS balance sheet accounts such as Other Current Liabilities of 4.1 M or Total Current Liabilities of 5 M provides information on Evaxion Biotech's total assets, liabilities, and equity, which is the actual value of Evaxion Biotech AS to its prevalent stockholders. By breaking down trends over time using Evaxion Biotech balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Evaxion Biotech AS latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Evaxion Biotech AS is a good buy for the upcoming year.

Evaxion Biotech Inventory

(2.36 Million)

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Evaxion Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Evaxion Biotech AS at a specified time, usually calculated after every quarter, six months, or one year. Evaxion Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Evaxion Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Evaxion currently owns. An asset can also be divided into two categories, current and non-current.

Evaxion Biotech Balance Sheet Chart

At this time, Evaxion Biotech's Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to rise to 140.70 in 2024, whereas Total Current Liabilities is likely to drop slightly above 5 M in 2024.

Short Long Term Debt Total Total Current Liabilities Total Stockholder Equity Property Plant And Equipment Net Other Current Assets Total Liab

Total Current Liabilities

Total Current Liabilities is an item on Evaxion Biotech balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Evaxion Biotech AS are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most accounts from Evaxion Biotech's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Evaxion Biotech AS current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	1.0M	1.2M	3.9M	4.1M
Short and Long Term Debt Total	3.7M	2.3M	10.9M	11.4M

Other Current Liab Short Long Term Debt Total

Evaxion Biotech balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Other Current Assets	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Short Term Debt	Common Stock	Net Tangible Assets	Other Assets
Total Assets		0.19	0.13	0.14	0.43	-0.07	-0.15	0.05	0.12	0.24	-0.01	-0.24	0.24	0.25	-0.08	-0.24	-0.09	0.09	-0.09	0.16	0.29	0.17	0.06	0.0	0.01	0.88
Short Long Term Debt Total	0.19		0.85	0.81	-0.16	0.51	0.24	-0.78	0.41	0.25	0.39	0.64	0.25	-0.67	-0.6	0.71	0.53	0.18	0.89	0.11	0.36	-0.09	0.47	0.68	0.64	0.02
Other Current Liab	0.13	0.85		0.62	-0.16	0.59	0.18	-0.94	0.64	0.23	0.6	0.75	0.23	-0.62	-0.64	0.89	0.59	0.42	0.9	0.09	0.35	0.0	-0.01	0.83	0.85	-0.06
Total Current Liabilities	0.14	0.81	0.62		-0.26	0.48	-0.05	-0.6	0.59	0.45	0.56	0.53	0.45	-0.77	-0.83	0.54	0.46	0.47	0.79	0.34	0.45	0.1	0.68	0.58	0.56	-0.11
Total Stockholder Equity	0.43	-0.16	-0.16	-0.26		-0.83	0.65	0.48	-0.46	-0.72	-0.6	-0.71	-0.72	0.35	0.43	-0.53	-0.82	-0.34	-0.47	-0.77	-0.7	-0.72	0.01	-0.48	-0.58	0.79
Property Plant And Equipment Net	-0.07	0.51	0.59	0.48	-0.83		-0.51	-0.81	0.71	0.76	0.79	0.93	0.76	-0.44	-0.6	0.78	1.0	0.47	0.74	0.72	0.79	0.67	-0.09	0.86	0.86	-0.49
Net Debt	-0.15	0.24	0.18	-0.05	0.65	-0.51		0.04	-0.42	-0.88	-0.45	-0.21	-0.88	0.03	0.38	0.01	-0.47	-0.41	0.03	-0.93	-0.81	-0.97	0.12	-0.12	-0.33	0.26
Retained Earnings	0.05	-0.78	-0.94	-0.6	0.48	-0.81	0.04		-0.73	-0.41	-0.74	-0.92	-0.41	0.63	0.67	-0.98	-0.81	-0.49	-0.94	-0.31	-0.51	-0.23	0.07	-0.92	-0.94	0.33
Accounts Payable	0.12	0.41	0.64	0.59	-0.46	0.71	-0.42	-0.73		0.61	0.98	0.67	0.61	-0.4	-0.77	0.69	0.66	0.93	0.66	0.55	0.61	0.51	-0.12	0.73	0.81	-0.23
Cash	0.24	0.25	0.23	0.45	-0.72	0.76	-0.88	-0.41	0.61		0.64	0.52	1.0	-0.35	-0.67	0.33	0.72	0.49	0.4	0.99	0.98	0.93	0.11	0.46	0.63	-0.25
Non Current Assets Total	-0.01	0.39	0.6	0.56	-0.6	0.79	-0.45	-0.74	0.98	0.64		0.73	0.64	-0.38	-0.72	0.73	0.74	0.91	0.68	0.6	0.63	0.56	-0.13	0.73	0.81	-0.38
Non Currrent Assets Other	-0.24	0.64	0.75	0.53	-0.71	0.93	-0.21	-0.92	0.67	0.52	0.73		0.52	-0.59	-0.6	0.92	0.94	0.4	0.87	0.46	0.57	0.38	-0.06	0.94	0.89	-0.55
Cash And Short Term Investments	0.24	0.25	0.23	0.45	-0.72	0.76	-0.88	-0.41	0.61	1.0	0.64	0.52		-0.35	-0.67	0.33	0.72	0.49	0.4	0.99	0.98	0.93	0.11	0.46	0.63	-0.25
Net Receivables	0.25	-0.67	-0.62	-0.77	0.35	-0.44	0.03	0.63	-0.4	-0.35	-0.38	-0.59	-0.35		0.84	-0.64	-0.43	-0.25	-0.77	-0.25	-0.36	-0.07	-0.49	-0.54	-0.65	0.44
Common Stock Shares Outstanding	-0.08	-0.6	-0.64	-0.83	0.43	-0.6	0.38	0.67	-0.77	-0.67	-0.72	-0.6	-0.67	0.84		-0.62	-0.55	-0.66	-0.75	-0.58	-0.66	-0.43	-0.35	-0.62	-0.79	0.28
Non Current Liabilities Total	-0.24	0.71	0.89	0.54	-0.53	0.78	0.01	-0.98	0.69	0.33	0.73	0.92	0.33	-0.64	-0.62		0.78	0.48	0.93	0.24	0.42	0.17	-0.1	0.87	0.91	-0.48
Capital Lease Obligations	-0.09	0.53	0.59	0.46	-0.82	1.0	-0.47	-0.81	0.66	0.72	0.74	0.94	0.72	-0.43	-0.55	0.78		0.4	0.74	0.69	0.76	0.63	-0.09	0.87	0.84	-0.49
Other Current Assets	0.09	0.18	0.42	0.47	-0.34	0.47	-0.41	-0.49	0.93	0.49	0.91	0.4	0.49	-0.25	-0.66	0.48	0.4		0.45	0.46	0.47	0.44	-0.13	0.43	0.59	-0.2
Total Liab	-0.09	0.89	0.9	0.79	-0.47	0.74	0.03	-0.94	0.66	0.4	0.68	0.87	0.4	-0.77	-0.75	0.93	0.74	0.45		0.29	0.49	0.13	0.25	0.84	0.86	-0.36
Net Invested Capital	0.16	0.11	0.09	0.34	-0.77	0.72	-0.93	-0.31	0.55	0.99	0.6	0.46	0.99	-0.25	-0.58	0.24	0.69	0.46	0.29		0.95	0.96	0.07	0.36	0.54	-0.31
Total Current Assets	0.29	0.36	0.35	0.45	-0.7	0.79	-0.81	-0.51	0.61	0.98	0.63	0.57	0.98	-0.36	-0.66	0.42	0.76	0.47	0.49	0.95		0.89	0.07	0.5	0.71	-0.2
Net Working Capital	0.17	-0.09	0.0	0.1	-0.72	0.67	-0.97	-0.23	0.51	0.93	0.56	0.38	0.93	-0.07	-0.43	0.17	0.63	0.44	0.13	0.96	0.89		-0.19	0.3	0.49	-0.28
Short Term Debt	0.06	0.47	-0.01	0.68	0.01	-0.09	0.12	0.07	-0.12	0.11	-0.13	-0.06	0.11	-0.49	-0.35	-0.1	-0.09	-0.13	0.25	0.07	0.07	-0.19		-0.09	-0.13	0.04
Common Stock	0.0	0.68	0.83	0.58	-0.48	0.86	-0.12	-0.92	0.73	0.46	0.73	0.94	0.46	-0.54	-0.62	0.87	0.87	0.43	0.84	0.36	0.5	0.3	-0.09		0.87	-0.29
Net Tangible Assets	0.01	0.64	0.85	0.56	-0.58	0.86	-0.33	-0.94	0.81	0.63	0.81	0.89	0.63	-0.65	-0.79	0.91	0.84	0.59	0.86	0.54	0.71	0.49	-0.13	0.87		-0.36
Other Assets	0.88	0.02	-0.06	-0.11	0.79	-0.49	0.26	0.33	-0.23	-0.25	-0.38	-0.55	-0.25	0.44	0.28	-0.48	-0.49	-0.2	-0.36	-0.31	-0.2	-0.28	0.04	-0.29	-0.36

Click cells to compare fundamentals

Evaxion Biotech Account Relationship Matchups

Evaxion Biotech balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	11.1M	12.0M	40.2M	(58.9M)	12.9M	13.5M
Short Long Term Debt Total	36K	20K	3.7M	2.3M	10.9M	11.4M
Other Current Liab	1.0M	1.2M	1.0M	1.2M	3.9M	4.1M
Total Current Liabilities	1.7M	4.9M	4.3M	3.8M	7.1M	5.0M
Total Stockholder Equity	9.4M	7.0M	(50.4M)	(72.7M)	(4.7M)	(5.0M)
Property Plant And Equipment Net	126K	457K	5.4M	4.7M	4.3M	2.4M
Net Debt	(9.5M)	(5.8M)	(28.5M)	(10.9M)	5.3M	5.6M
Retained Earnings	(15.8M)	(27.3M)	(50.4M)	(72.7M)	(108.0M)	(102.6M)
Accounts Payable	646K	3.7M	2.8M	2.1M	2.7M	1.9M
Cash	9.6M	5.8M	32.2M	13.2M	5.6M	5.3M
Non Current Assets Total	126K	6.1M	5.5M	5.0M	4.5M	3.4M
Cash And Short Term Investments	9.6M	5.8M	32.2M	13.2M	5.6M	5.3M
Net Receivables	931K	1.8M	1.9M	789K	1.1M	1.1M
Liabilities And Stockholders Equity	11.1M	12.0M	(42.7M)	(58.9M)	12.9M	13.5M
Non Current Liabilities Total	682K	2.7M	3.4M	10.0M	10.5M	11.1M
Capital Lease Obligations	36K	20K	2.5M	2.3M	2.2M	1.1M
Other Current Assets	468.0K	6.3M	3.2M	2.5M	1.7M	2.3M
Total Liab	1.7M	4.9M	7.7M	13.7M	17.6M	18.5M
Net Invested Capital	9.4M	7.0M	33.6M	16.3M	3.9M	3.7M
Total Current Assets	11.0M	5.8M	34.7M	14.0M	8.4M	13.3M
Accumulated Other Comprehensive Income	22.7M	31.7M	79.1M	(3.7M)	(3.8M)	(3.6M)
Net Working Capital	9.2M	6.0M	30.4M	13.2M	1.3M	1.2M
Short Term Debt	36K	40K	440K	439K	485K	460.8K
Common Stock	2.5M	2.6M	3.8M	3.9M	5.9M	3.6M
Other Assets	25K	694K	191K	(78.0M)	134.0	140.7
Inventory	(6.0)	(6.9M)	(1.9M)	(2.5M)	(2.2M)	(2.4M)
Other Stockholder Equity	(169K)	34.3M	(82.9M)	80.7M	101.1M	106.2M
Capital Stock	2.5M	2.6M	3.8M	3.9M	5.9M	3.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Evaxion Stock Analysis

When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Evaxion Historical Balance Sheet

Evaxion Biotech Inventory

(2.36 Million)

About Evaxion Balance Sheet Analysis

Evaxion Biotech Balance Sheet Chart

Total Current Liabilities

Total Stockholder Equity

Property Plant And Equipment Net

Other Current Assets

Total Liab

Evaxion Biotech balance sheet Correlations

Evaxion Biotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Evaxion Biotech balance sheet Accounts

Also Currently Popular

Additional Tools for Evaxion Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Capital Lease Obligations	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Net Invested Capital	+ 0.99	Cash
Net Invested Capital	+ 0.99	Cash And Short Term Investments
Non Current Assets Total	+ 0.98	Accounts Payable
Total Current Assets	+ 0.98	Cash

Non Current Liabilities Total	- 0.98	Retained Earnings
Net Working Capital	- 0.97	Net Debt
Net Tangible Assets	- 0.94	Retained Earnings
Total Liab	- 0.94	Retained Earnings
Retained Earnings	- 0.94	Other Current Liab
Net Invested Capital	- 0.93	Net Debt